Biolase, Inc
BIOLDelisted Sep 6, 2024- Industry
- Dental Equipment & Supplies
- SEC CIK
- 0000811240
Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Biolase, Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 42 | 47 | +5 |
| Shares | 17.7M | 22.5M | +4.85M (+27.4%) |
| Value | $12.4M | $14.4M | +$2.06M (+16.6%) |
New holders (11)
Institutions that held Biolase, Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 1,254,547 | $802.0K | 0.08% |
| Essex Investment Management Co LLC | 799,189 | $511.0K | 0.06% |
| Marshall Wace, LLP | 752,003 | $481.0K | 0.00% |
| Commonwealth Equity Services, LLC | 49,396 | $31.0K | 0.00% |
| Atom Investors LP | 47,168 | $30.0K | 0.01% |
| Credit Suisse AG | 46,016 | $29.0K | 0.00% |
| Jane Street Group, LLC | 40,874 | $26.0K | 0.00% |
| Two Sigma Securities, LLC | 30,030 | $19.0K | 0.00% |
| Zhang Financial LLC | 12,500 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,371 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 100 | $0 | 0.00% |
Sold out (6)
Institutions that held Biolase, Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Algert Global LLC | 18,700 | $13.0K |
| Larson Financial Group LLC | 17,953 | $13.0K |
| Scotia Capital Inc. | 10,000 | $7.00K |
| Summit X, LLC | 10,000 | $7.00K |
| Spire Wealth Management | 5,000 | $3.00K |
| Barclays PLC | 50 | $0 |